Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Invested Capital: 2013-2018

Historic Invested Capital for Armata Pharmaceuticals (ARMP) over the last 5 years, with Sep 2018 value amounting to $8.8 million.

  • Armata Pharmaceuticals' Invested Capital fell 9.85% to $8.8 million in Q3 2018 from the same period last year, while for Sep 2018 it was $8.8 million, marking a year-over-year decrease of 9.85%. This contributed to the annual value of $7.7 million for FY2017, which is 20.49% down from last year.
  • Per Armata Pharmaceuticals' latest filing, its Invested Capital stood at $8.8 million for Q3 2018, which was down 23.90% from $11.6 million recorded in Q2 2018.
  • In the past 5 years, Armata Pharmaceuticals' Invested Capital ranged from a high of $408.5 million in Q1 2018 and a low of -$34.0 million during Q1 2014.
  • Moreover, its 3-year median value for Invested Capital was $9.8 million (2017), whereas its average is $47.4 million.
  • Per our database at Business Quant, Armata Pharmaceuticals' Invested Capital plummeted by 54.10% in 2017 and then spiked by 6,044.18% in 2018.
  • Armata Pharmaceuticals' Invested Capital (Quarterly) stood at $3.4 million in 2014, then spiked by 269.92% to $12.7 million in 2015, then fell by 23.53% to $9.7 million in 2016, then decreased by 20.49% to $7.7 million in 2017, then dropped by 9.85% to $8.8 million in 2018.
  • Its Invested Capital stands at $8.8 million for Q3 2018, versus $11.6 million for Q2 2018 and $408.5 million for Q1 2018.